DOCU vs INO · P/E 15, rev $1.71B vs $88.0M cap
DocuSign Inc (DOCU) versus Inovio Pharmaceuticals Inc (INO) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. INO currently screens at market cap $88.0M.
Not investment advice. Open the DOCU and INO stock pages for the full models.
Not investment advice.